A Randomised, Double-Blind, Placebo-Controlled Trial of Actovegin in Patients with Post-Stroke Cognitive Impairment: ARTEMIDA Study Design.
about
Post-stroke dementia - a comprehensive review.ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive Impairment.Towards the concept of disease-modifier in post-stroke or vascular cognitive impairment: a consensus reportDiabetes and the brain: issues and unmet needs.Understanding and preventing the development of post-stroke dementia.Pharmacotherapy to Enhance Cognitive and Motor Recovery Following Stroke.
P2860
A Randomised, Double-Blind, Placebo-Controlled Trial of Actovegin in Patients with Post-Stroke Cognitive Impairment: ARTEMIDA Study Design.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A Randomised, Double-Blind, Pl ...... irment: ARTEMIDA Study Design.
@en
A Randomised, Double-Blind, Pl ...... irment: ARTEMIDA Study Design.
@nl
type
label
A Randomised, Double-Blind, Pl ...... irment: ARTEMIDA Study Design.
@en
A Randomised, Double-Blind, Pl ...... irment: ARTEMIDA Study Design.
@nl
prefLabel
A Randomised, Double-Blind, Pl ...... irment: ARTEMIDA Study Design.
@en
A Randomised, Double-Blind, Pl ...... irment: ARTEMIDA Study Design.
@nl
P2093
P2860
P356
P1476
A Randomised, Double-Blind, Pl ...... irment: ARTEMIDA Study Design.
@en
P2093
Alla Guekht
Ingmar Skoog
Martin Eeg
Ulf Vigonius
Vladimir Zakharov
P2860
P304
P356
10.1159/000357122
P577
2013-01-01T00:00:00Z